Chemoinformaics analysis of Potassium isolespedezate
Molecular Weight | 380.39 | nRot | 5 |
Heavy Atom Molecular Weight | 363.254 | nRig | 14 |
Exact Molecular Weight | 380.051 | nRing | 2 |
Solubility: LogS | -0.385 | nHRing | 1 |
Solubility: LogP | -1.414 | No. of Aliphatic Rings | 1 |
Acid Count | 1 | No. of Aromatic Rings | 1 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 1 |
nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 17 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 9 | No. of Arom Bond | 6 |
nHA | 9 | APOL | 86.6635 |
nHD | 5 | BPOL | 22.2625 |
QED | 0.283 |
Synth | 4.069 |
Natural Product Likeliness | 1.657 |
NR-PPAR-gamma | 0.002 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.002 |
Pgp-sub | 0.032 |
HIA | 0.884 |
CACO-2 | -5.936 |
MDCK | 0.0000497 |
BBB | 0.241 |
PPB | 0.722616 |
VDSS | 0.254 |
FU | 0.291032 |
CYP1A2-inh | 0.098 |
CYP1A2-sub | 0.021 |
CYP2c19-inh | 0.025 |
CYP2c19-sub | 0.059 |
CYP2c9-inh | 0.004 |
CYP2c9-sub | 0.216 |
CYP2d6-inh | 0.005 |
CYP2d6-sub | 0.12 |
CYP3a4-inh | 0.014 |
CYP3a4-sub | 0.017 |
CL | 1.668 |
T12 | 0.925 |
hERG | 0.064 |
Ames | 0.04 |
ROA | 0.079 |
SkinSen | 0.642 |
Carcinogencity | 0.28 |
EI | 0.174 |
Respiratory | 0.024 |
NR-Aromatase | 0.005 |
Antiviral | Yes |
Prediction | 0.619217 |